Researchers from New York City-based Northwell Health conducted an observational study of 48,012 adult patients admitted to 12 of its hospitals between March 1 and June 1. On admission, 189 patients were identified with pancreatitis, of which 32 patients (17 percent) were diagnosed with COVID-19.
In 69 percent of cases for patients with both COVID-19 and pancreatitis, the origins of pancreatitis were unknown, implicating COVID-19 as the cause, study authors state.
In addition, the need for mechanical ventilation was higher with among pancreatitis patients with COVID-19 (28 percent), than those without COVID-19 (6 percent). The length of stay nearly quadrupled for pancreatitis patients with COVID-19.
Study findings were published in the journal Gastroenterology.
More articles on patient safety & outcomes:
1 in 3 patients may have neurological issues after COVID-19, experts say
Dartmouth-Hitchcock performs 1,000th transplant
Black newborn mortality rate cut in half when cared by Black physicians
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
